Showing results (61-70 of 70) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Oncotarget|July 11, 2018
Integrated treatment using intraperitoneal radioimmunotherapy and positron emission tomography-guided surgery with 64Cu-labeled cetuximab to treat early- and late-phase peritoneal dissemination in human gastrointestinal cancer xenograftsYukie Yoshii, Mitsuyoshi Yoshimoto, Hiroki Matsumoto, et al.Physics in Medicine and Biology|January 3, 2025
A whole gamma imaging prototype for higher quantitative imaging of89Zr-labeled antibodies in a tumor mouse modelSodai Takyu, Hideaki Tashima, Miwako Takahashi, et al.Nuclear Medicine and Biology|June 18, 2025
Trithiol ligand provides tumor-targeting 191Pt-complexes with high molar activity and promising in vivo propertiesHonoka Obata, Atsushi B Tsuji, Yutian Feng, et al.Nuclear Medicine Communications|May 7, 2020
64Cu-labeled minibody D2101 visualizes CDH17-positive gastric cancer xenografts with short waiting timeKentaro Fujiwara, Hiroki Akiba, Atsushi B Tsuji, et al.ACS Omega|February 10, 2025
Evaluation of the Gly-Phe-Lys Linker to Reduce the Renal Radioactivity of a [64Cu]Cu-Labeled Multimeric cRGD PeptideZhao-Hui Jin, Mélissa Degardin, Takako Furukawa, et al.Plos One|November 17, 2015
Immuno-PET Imaging of HER3 in a Model in which HER3 Signaling Plays a Critical RoleQinghua Yuan, Takako Furukawa, Takahiro Tashiro, et al.International Journal of Molecular Sciences|May 28, 2022
In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized 64Cu-Intraperitoneal Radioimmunotherapy against Peritoneal Dissemination of Pancreatic Cancer: A Feasibility StudyFukiko Hihara, Hiroki Matsumoto, Mitsuyoshi Yoshimoto, et al.Scientific Reports|March 12, 2020
Immuno-OpenPET: a novel approach for early diagnosis and image-guided surgery for small resectable pancreatic cancerYukie Yoshii, Hideaki Tashima, Yuma Iwao, et al.Nuclear Medicine Communications|June 8, 2021
Usefulness of PET-guided surgery with 64Cu-labeled cetuximab for resection of intrapancreatic residual tumors in a xenograft mouse model of resectable pancreatic cancerChika Igarashi, Yukie Yoshii, Hideaki Tashima, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|October 24, 2022
Delivery of aPD-L1 antibody to i.p. tumors via direct penetration by i.p. route: Beyond EPR effectMayu Yamamoto, Taiki Kurino, Reiko Matsuda, et al.Pageof 7